Clinical Trials in Bunkyō-Ku, Tokyo
21 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals454 enrolled94 locationsNCT06510374
Recruiting
Phase 3
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Non-small Cell Lung CancerAdvanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.480 enrolled61 locationsNCT07185997
Recruiting
Product Surveillance Registry
Cardiac Rhythm DisordersDigestive disordersMinimally Invasive Surgical Procedures+13 more
Medtronic100,000 enrolled391 locationsNCT01524276
Recruiting
Not Applicable
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Heart DiseasesCoronary Artery DiseaseCoronary Artery Bypass Grafting
Weill Medical College of Cornell University2,300 enrolled146 locationsNCT04124120
Recruiting
Phase 3
MSA-01 in Multiple System Atrophy
Multiple System Atrophy (MSA)
Tokyo University140 enrolled12 locationsNCT07446894
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Non-small Cell Lung Cancer
Summit Therapeutics780 enrolled202 locationsNCT06767514
Recruiting
Phase 2
ONO-4538 Study in Patients With Richter's Transformation
Richter's Transformation
Ono Pharmaceutical Co., Ltd.14 enrolled10 locationsNCT06936943
Recruiting
Phase 1
A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
NSCLCSolid Tumor
Ono Pharmaceutical Co., Ltd.60 enrolled15 locationsNCT06816108
Recruiting
Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo740 enrolled243 locationsNCT05215340
Recruiting
Phase 3
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
Osteoarthritis of the knee
CellSeed Inc.96 enrolled6 locationsNCT06549686
Recruiting
Not Applicable
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
OsteoporosisHip FracturesFragility Fracture
AgNovos Healthcare, LLC2,400 enrolled54 locationsNCT04796350
Recruiting
Phase 3
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.450 enrolled22 locationsNCT06238843
Recruiting
Not Applicable
Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds
Diabetic Foot UlcerVenous Leg Ulcer
MiMedx Group, Inc.75 enrolled5 locationsNCT06236750
Recruiting
Not Applicable
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
Pancreatic PseudocystPancreatic Fluid CollectionWalled-off Necrosis+1 more
Tokyo University70 enrolled21 locationsNCT05451901
Recruiting
Phase 3
Phase III Trial of Stage I Ovarian Cancer After Surgery
Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group360 enrolled103 locationsNCT04063527